ARTICLE | Company News
Lidak deal
July 25, 1994 7:00 AM UTC
Boryung Pharmaceuticals Co. Ltd. received a license for the Korean development of Lidakol, LDAKA's anti-viral compound to treat herpes. Boryung will be responsible for regulatory approval, marketing a...